MENU
BCDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCardia (BCDA) Ownership - Who owns BioCardia?
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs... Show more
Profile
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.47M
P/E Ratio
N/A
Total Cash
980K
Projected Growth
N/A
Total Debt
745K
Revenue
N/A
Risk (Beta)
0.85
Dividend Yield
N/A
Total Cash/Share
0.17
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCDA
Capitalization
11.5M
P/E Ratio
N/A
Risk (Beta)
0.85
Dividend Yield
N/A
Total Cash
980K
Total Cash/Share
0.17
Total Debt
745K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-1.89M
P/B Ratio
13.64
Cash Flow
N/A
Earnings
-1.68
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
0.33
Current Revenue Per Employee
150.00
Dividends Per Share - Security
N/A
EBITDA
-8.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-353.24
Shares Held By Institutions
747K
Shares Outstanding - Current
5.8M
Total Liabilities
3.98M
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.092
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a clinical-stage regenerative medicine company, which develops novel therapeutics for cardiovascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
320 Soquel Way
Phone
+1 650 226-0120
Employees
20
Web
https://www.biocardia.com